NASDAQ NMS - GLOBAL MARKET · LQDA
-1.20% · -$0.9200 · Vol Not reported
Pre-market · updated 07:02:28 ET
Liquidia Corp

Liquidia Corp

Pharmaceuticals
$76.00

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is LQDA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Liquidia Corp
PHARMACEUTICAL PREPARATIONS
Listed since
2018
Employees
216
Country
US

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$76.92
Last session
Day high
$76.92
Last session
Day low
$76.92
Last session
Previous close
$76.92
52W high
$76.92
-1.20% from high
52W low
$65.25
92% of range
Market cap
$6.7B
P/E
306.67×
EPS
$-0.4600
Shares out
88.9M
VWAP
$76.92
Last session
Price history computed in-house
1W
+6.94%
SMA 50 $71.57 · above
SMA 200 $71.57 · above
52W position 92%
Veridion warehouse edge

Warehouse intelligence for LQDA.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

LQDA insider activity

Liquidia Corp

Score
Coverage building
Pressure
Net selling
Filings
128
Buys / sells
17 / 111
Net value
-$158.8M
Insiders
14
Named filers
BM
Bloch Stephen M
Insider
Leadership
KS
Krepp Sarah
Insider
Leadership
KS
Khindri Sanjeev
Insider
Leadership
Cluster

3 insiders bought in the last 90 days

Net pressure

Net selling: -$158.8M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-242026-06-22Bloch Stephen MInsidersell$76.1830,500880,073$2.3MSEC Form 4
2026-06-242026-06-22Bloch Stephen MInsidersell$75.5469,500910,573$5.3MSEC Form 4
2026-06-162026-06-15Bloch Stephen MInsidersell$72.082,322980,073$167KSEC Form 4
2026-06-162026-06-15Bloch Stephen MInsidersell$71.4282,740982,395$5.9MSEC Form 4
2026-06-162026-06-12Bloch Stephen MInsidersell$72.1513,0951,065,135$945KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 123 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

LQDA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LQDA in this window.
Lobbying spend

LQDA lobbying filings, year to date.

Registered lobbying filings matched to Liquidia Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LQDA in this window.
Latest news · LQDA
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for LQDA.
Options
Sovereign unlock shows live options positioning for LQDA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.